Archives

by in
Entry Author Date Location
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
Memorial Sloan-Kettering and Eureka Go After ‘Undruggable’ Targets 03/21/13 New York
Allozyne Conducts Round of Employee ‘Furloughs’ 03/15/13 Seattle
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
The Holy Grail of Drug Development: Small Molecules with the Power of Biologics 02/14/13 Boston
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
Genentech, ImmunoGen Souped-Up Breast Cancer Drug Extends Lives 10/01/12 San Francisco
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Theraclone Takes 2nd Antibody into the Clinic Against Common Virus 06/14/12 Seattle
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
SD Biotech Roundup: Elevation Pharmaceuticals, BioSurplus, and More 05/17/12 San Diego
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic 09/21/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Xoma CEO Resigns After Four-Year Push To Go Commercial 08/31/11 San Francisco
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Page 1 of 4 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.